• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.

作者信息

Okpala I E, Olatunji P O, Okunade M A, Ogunsanwo B A, Jeje O M, Shokunbi W A, Essien E M

机构信息

Department of Haematology, University College Hospital, Ibadan, Nigeria.

出版信息

Afr J Med Med Sci. 1990 Dec;19(4):313-7.

PMID:2128003
Abstract

Patients with acute lymphoblastic leukaemia (ALL) seen in University College Hospital, Ibadan, Nigeria, still have low rates of complete remission and relatively short survival. Yet the overall prognosis was expected to have improved because the proportions of adults, males and people of low socio-economic class among the patients have decreased steadily over the past three decades. Possible causes of the persistent poor performance were sought for in 30 new ALL patients seen in the hospital over a period of 2 years and 9 months. Unfavourable prognostic factors, lack of standard cytotoxic drugs, inadequate supportive care and absence of modern facilities for therapy combined to make their disease outcome worse than expected.

摘要

相似文献

1
Prognosis of acute lymphoblastic leukaemia in Ibadan, Nigeria.
Afr J Med Med Sci. 1990 Dec;19(4):313-7.
2
Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.年龄对儿童和青少年急性淋巴细胞白血病的预后影响:来自ALL-BFM 86、90和95试验的数据。
Klin Padiatr. 2005 Nov-Dec;217(6):310-20. doi: 10.1055/s-2005-872515.
3
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.高剂量环磷酰胺、长春新碱、阿霉素及地塞米松(Hyper-CVAD)方案,一种剂量密集型方案,用于成人急性淋巴细胞白血病的长期随访结果。
Cancer. 2004 Dec 15;101(12):2788-801. doi: 10.1002/cncr.20668.
4
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.采用超分割环磷酰胺、长春新碱、阿霉素和地塞米松/甲氨蝶呤-阿糖胞苷方案进行急性淋巴细胞白血病诱导化疗时缓解持续时间与高血糖之间的关系。
Cancer. 2004 Mar 15;100(6):1179-85. doi: 10.1002/cncr.20071.
5
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.儿童急性淋巴细胞白血病 AIEOP-ALL-95 试验的长期结果:基于柏林-法兰克福-明斯特化疗方案对 DNA 指数预后价值的洞察
J Clin Oncol. 2008 Jan 10;26(2):283-9. doi: 10.1200/JCO.2007.12.3927.
6
[Acute lymphoblastic leukemia in adults: results of the DATOP-79 protocol].[成人急性淋巴细胞白血病:DATOP - 79方案的结果]
Med Clin (Barc). 1988 Nov 19;91(17):653-7.
7
Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.在成人急性淋巴细胞白血病缓解诱导期间外周血和骨髓原始细胞的持续存在根据治疗强度预示着不良预后。
Clin Cancer Res. 1999 Sep;5(9):2491-7.
8
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.强化治疗在急性淋巴细胞白血病婴儿中的作用:两项连续的意大利儿童血液学和肿瘤学协会(AIEOP)研究结果
Haematologica. 2006 Apr;91(4):534-7. Epub 2006 Mar 15.
9
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].资源有限国家的急性淋巴细胞白血病治疗;印度20年间使用单一方案的经验教训[已修正]
Eur J Cancer. 2005 Jul;41(11):1570-83. doi: 10.1016/j.ejca.2004.11.004. Epub 2005 Jan 5.
10
Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.采用AL90方案治疗的儿童急性淋巴细胞白血病的结局:治疗反应和性别差异对预后因素的影响。
Med Pediatr Oncol. 2001 Jul;37(1):10-9. doi: 10.1002/mpo.1156.